As the prevalence of obesity increases worldwide, clinicians will be more and more
frequently confronted with obese, critically ill patients. Optimal administration of antibiotics is …

Résumé Comme la prévalence de l'obésité augmente dans le monde, le clinicien sera de
plus en plus fréquemment confronté à des patients obèses en réanimation. Il est …

As the prevalence of obesity continues to rise significantly worldwide, an increasing number
of overweight patients are expected to present to hospital with various pathological …

Obesity is a significant global public health concern that is associated with an elevated risk
of comorbidities as well as severe postoperative and nosocomial infections. The treatment of …

Obesity is a growing societal and population health problem the prevalence of which has
increased significantly in the recent decades. Pathophysiological changes associated with …

The increased prevalence of obesity presents challenges for clinicians aiming to provide
optimised antimicrobial dosing in the intensive care unit. Obesity is likely to exacerbate the …

Physiologic alterations seen in obesity commonly impact the pharmacokinetics (PK) and
pharmacodynamics (PD) of antibiotics and may result in suboptimal dosing in this …

Physiologic alterations seen in obesity commonly impact the pharmacokinetics (PK) and
pharmacodynamics (PD) of antibiotics and may result in suboptimal dosing in this …

The increasing numbers of critically ill obese patients in the intensive care unit (ICU) and the
high frequency of antimicrobial prescription in these patients present a challenge for …

The prevalence of obesity has increased considerably in the last few decades.
Pathophysiological changes in obese patients lead to pharmacokinetic (PK) and …